Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant

Samantha M Morrissey1, Fan Zhang2, Chuanlin Ding3

  • 1Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA; Division of Immunotherapy, The Hiram C. Polk, Jr., MD Department of Surgery, Immuno-Oncology Program, Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, USA.

Cell Metabolism
|September 24, 2021
PubMed

Insights

Tumor exosomes reprogram macrophage metabolism, promoting an immunosuppressive phenotype crucial for metastasis. This highlights a link between exosomes, metabolism, and cancer spread.

Area of Science:

  • Cancer Biology
  • Immunology
  • Metabolic Reprogramming

Background:

  • Pre-metastatic niche formation requires immunosuppressive macrophages.
  • The mechanisms driving macrophage polarization in this niche are poorly understood.

Purpose of the Study:

  • To elucidate how tumor-derived exosomes (TDEs) induce an immunosuppressive phenotype in macrophages.
  • To investigate the role of metabolic reprogramming in this process.

Main Methods:

  • Investigated TDEs' effect on macrophage polarization and PD-L1 expression.
  • Analyzed metabolic pathways, including glucose uptake and lactate production.
  • Utilized NF-kB and TLR2 signaling pathway analysis.
  • Examined patient lymph node samples from non-small-cell lung cancer patients.

Main Results:

  • TDEs polarize macrophages to an immunosuppressive phenotype via NF-kB-dependent, glycolytic reprogramming.
  • TDEs increase glucose uptake and NOS2 expression, leading to lactate production.
  • Lactate enhances NF-kB signaling, further increasing PD-L1 expression.
  • Macrophage PD-L1 correlates with GLUT-1 and YKT6 in patient samples.

Conclusions:

  • TDEs drive macrophage immunosuppression through metabolic reprogramming, linking exosomes, metabolism, and metastasis.
  • This mechanism is critical for establishing the pre-metastatic niche.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K